In Escalation: All Patients With Solid Tumors and Lymphoma
1 clinical trials · Condition
◉ Watch In Escalation: All Patients With Solid Tumors and Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab (NCT04261439) | Novartis Pharmaceuticals | 2020-02-27 |
Track In Escalation: All Patients With Solid Tumors and Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.